Video

Hayes Dansky from Janssen Pharmaceuticals: Xarelto Continues to Show Positive Results in Practice

Author(s):

As Xarelto is used in practice by more doctors researchers at Janssen Pharmaceuticals are getting a better sense of its efficacy beyond the extensive clinical trials it underwent.

As Xarelto is used in practice by more doctors researchers at Janssen Pharmaceuticals are getting a better sense of its efficacy beyond the extensive clinical trials it underwent.

Hayes Dansky, MD, of Janssen Pharmaceuticals discussed how real world data can help expand the usage of the anticoagulant and what that can mean for overall patient care during the American College of Cardiology's 65th Annual Scientific Sessions and Expo in Chicago.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.